{{Rsnum
|rsid=10870077
|Gene=CARD9
|Chromosome=9
|position=136369439
|Orientation=plus
|GMAF=0.3641
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=CARD9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 21.5 | 50.8 | 27.7
| HCB | 44.4 | 51.1 | 4.4
| JPT | 56.8 | 36.4 | 6.8
| YRI | 52.4 | 39.7 | 7.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 44.4 | 51.1 | 4.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{omim
|desc=INFLAMMATORY BOWEL DISEASE 1; IBD1
|id=266600
|rsnum=10870077
}}

{{PharmGKB
|RSID=rs10870077
|Name_s=
|Gene_s=CARD9
|Feature=
|Evidence=PubMed ID:18439550
|Annotation=In a case - control study, this variant was shown to be associated with susceptibility to Crohn's Disease and to Ulcerative Colitis.
|Drugs=
|Drug Classes=
|Diseases=Colitis, Ulcerative; Crohn Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA161614199
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10870077
|overall_frequency_n=41
|overall_frequency_d=128
|overall_frequency=0.320312
|n_genomes=31
|n_genomes_annotated=0
|n_haplomes=34
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}